{
  "id": 4034775,
  "title": "Xenon Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)",
  "url": "https://urgent.news/2026/08/28/xenon-pharmaceuticals-reports-inducement-grants-under-nasdaq-listing",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-08-28T20:01:54.000Z",
  "source": {
    "name": "Financial Post",
    "slug": "financial-post",
    "url": "https://financialpost.com/globe-newswire/xenon-pharmaceuticals-reports-inducement-grants-under-nasdaq-listing-rule-5635c4-13"
  },
  "original_language": "en",
  "account": null,
  "summary": "VANCOUVER, BC and BOSTON, MA, Aug. 28, 2026 (GLOBE NEWSWIRE) — Xenon Pharmaceuticals Inc. (Nasdaq: XENE), a neuroscience-focused biopharmaceutical company dedicated to drug discovery, clinical development, and commercialization of life-changing therapeutics for patients in need, today announced equity inducement grants to five new non-officer employees consisting of an aggregate of 13,450 share…",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}